A multi-center longitudinal prospective cohort, run by a team of allergists dedicated to improving clinical care while promoting public health and scientific discovery, through studying and refining the evaluation and management of drug allergies, particularly penicillin allergies.
About USDAR
Hear more about how the United States Drug Allergy Registry pushes research forward and improves clinical care, from our Principal Investigator, Dr. Kimberly Blumenthal.
